Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz

Clinical trial NCT05041010 · UNKNOWN

Trial details

NCT number: NCT05041010
Sponsor: GNT Pharma
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Ischemic Stroke

Start date: 2021-12-25
Primary completion: 2024-06-01
Enrollment: 496

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.